Fulgent Genetics to Announce Fourth Quarter and Full Year 2018 Financial Results on Thursday February 28, 2019
February 20 2019 - 08:00AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”) today announced that it will release its fourth quarter
and full year 2018 financial results after the market closes on
Thursday February 28, 2019. The company’s Chairman and Chief
Executive Officer Ming Hsieh and its Chief Financial Officer Paul
Kim will host a conference call for the investment community the
same day at 4:30 PM ET (1:30 PM PT) to discuss the results and
answer questions.
The call can be accessed through a live audio webcast in the
Investors section of the company’s website,
http://ir.fulgentgenetics.com, and through a live conference call
by dialing (855) 321-9535 using the conference ID 1076324. An audio
replay will be available in the Investors section of the company’s
website or by calling (855) 859-2056 using passcode 1076324 through
March 7, 2019.
About Fulgent Genetics
Fulgent Genetics is a technology company with a focus on
offering comprehensive genetic testing to provide physicians with
clinically actionable diagnostic information they can use to
improve the quality of patient care. The company has developed a
proprietary technology platform that allows it to offer a broad and
flexible test menu and continually expand and improve its
proprietary genetic reference library, while maintaining accessible
pricing, high accuracy and competitive turnaround times. The
company believes its test menu, which currently offers more genes
for testing than its competitors in today's market, enables it to
provide expansive options for test customization and clinically
actionable results.
Investor Relations Contacts:The Blueshirt
GroupNicole Borsje, 415-217-2633, nborsje@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Mar 2023 to Mar 2024